fluorexon has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, RJ; Li, H; Liu, S; Lu, Y; Marcucci, G; Piao, L; Ratnam, M; Wu, J | 1 |
| Legrand, O; Marie, JP; Perrot, JY; Simonin, G; Zittoun, R | 1 |
2 other study(ies) available for fluorexon and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acid.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Colony-Forming Units Assay; Doxorubicin; Drug Delivery Systems; Female; Fluoresceins; Folate Receptor 2; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred ICR; Tissue Distribution; Tretinoin; Up-Regulation | 2010 |
Both Pgp and MRP1 activities using calcein-AM contribute to drug resistance in AML.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Pair Mismatch; Biological Transport; Calcium; Cyclosporine; DNA-Binding Proteins; Drug Resistance, Multiple; Female; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Genes, MDR; Humans; K562 Cells; Leukemia, Myeloid, Acute; Male; Multidrug Resistance-Associated Proteins; MutS Homolog 3 Protein; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1999 |